CureVac N.V. (CVAC)
NASDAQ: CVAC · Real-Time Price · USD
5.05
-0.07 (-1.37%)
At close: Dec 12, 2025, 4:00 PM EST
5.29
+0.24 (4.75%)
After-hours: Dec 12, 2025, 6:48 PM EST
CureVac Market Cap
CureVac has a market cap or net worth of $1.14 billion as of December 12, 2025. Its market cap has increased by 85.02% in one year.
Market Cap
1.14B
Enterprise Value
690.11M
1-Year Change
85.02%
Ranking
Category
Stock Price
$5.05
Market Cap Chart
Since the IPO on August 14, 2020, CureVac's market cap has decreased from $9.84B to $1.14B, a decrease of -88.44%. That is a compound annual growth rate of -33.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 12, 2025 | 1.14B | 48.67% |
| Dec 31, 2024 | 764.91M | -18.86% |
| Dec 29, 2023 | 942.72M | -17.82% |
| Dec 30, 2022 | 1.15B | -82.12% |
| Dec 31, 2021 | 6.42B | -55.14% |
| Dec 31, 2020 | 14.31B | 45.43% |
| Aug 14, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 903.78B |
| Johnson & Johnson | 505.98B |
| AbbVie | 395.86B |
| UnitedHealth Group | 305.02B |
| AstraZeneca | 282.91B |
| Novartis AG | 256.01B |
| Merck & Co. | 245.75B |
| Novo Nordisk | 223.42B |